Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

A personalized alert tool improve use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for ...

Angiotensin receptor blockers (ARBs), particularly losartan, are associated with a lower risk for incident epilepsy in patients with hypertension and no preexisting stroke or cardiovascular disease ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...

A class of drugs already on the market to lower blood pressure appears to reduce adults' risk of developing epilepsy, Stanford Medicine researchers and their colleagues have discovered. The finding ...

Video: Using ACE Inhibitors and Angiotensin Receptor Blockers in ADPKD —David Charytan, MD, MSc, Chief of the Nephrology Division at New York University Grossman School of Medicine, discusses the use ...

Eli Lilly & Co. has described compounds acting as angiotensin AT2 receptor (AGTR2) antagonists reported to be useful for the treatment of pain.

Receiving a cancer diagnosis during hospitalization and associations with care outcomes.

Treatment decision patterns post–enfortumab vedotin plus pembrolizumab in metastatic urothelial cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...